Literature DB >> 30548929

AHNS series: Do you know your guidelines? Diagnosis and management of salivary gland tumors.

Avinash V Mantravadi1, Michael G Moore2, Christopher H Rassekh3.   

Abstract

This article is the next installment of the series "Do you know your guidelines" presented by the Education Committee of the American Head and Neck Society. Guidelines for the workup and management of tumors of the major and minor salivary glands are reviewed.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  minor salivary glands; neoplasms; parotid gland; sublingual gland; submandibular gland

Year:  2018        PMID： 30548929     DOI： 10.1002/hed.25499

Source DB:  PubMed          Journal:  Head Neck        ISSN： 1043-3074            Impact factor:   3.147


  5 in total

1.  Simultaneous Expression of PD-1 and PD-L1 in Peripheral and Central Immune Cells and Tumor Cells in the Benign and Malignant Salivary Gland Tumors Microenvironment.

Authors:  Mohammad Reza Haghshenas; Nasrollah Erfani; Sajjad Gerdabi; Fatemeh Asadian; Razie Kiani; Bijan Khademi
Journal:  Head Neck Pathol       Date:  2022-09-28

2.  Preoperative evaluation and treatment consideration of parotid gland tumors.

Authors:  Katri Aro; Jarkko Korpi; Jussi Tarkkanen; Antti Mäkitie; Timo Atula
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-07-20

3.  Salivary gland disease in the era of COVID-19 pandemic.

Authors:  Liuba Soldatova; Christopher H Rassekh; Zubair W Baloch; Jalal B Jalaly; Neda I Sedora-Roman; Laurie L Loevner; David M Cognetti; Robert L Witt; Pavel Dulguerov
Journal:  Head Neck       Date:  2020-04-28       Impact factor: 3.147

4.  Real-World Outcomes and Prognostic Factors in Patients Receiving Nivolumab Therapy for Recurrent or Metastatic Head and Neck Carcinoma.

Authors:  Ryusuke Hori; Shogo Shinohara; Tsuyoshi Kojima; Hiroki Kagoshima; Morimasa Kitamura; Ichiro Tateya; Hisanobu Tamaki; Yohei Kumabe; Ryo Asato; Hiroyuki Harada; Yoshiharu Kitani; Takashi Tsujimura; Keigo Honda; Kazuyuki Ichimaru; Koichi Omori
Journal:  Cancers (Basel)       Date:  2019-09-06       Impact factor: 6.639

5.  Prognostic Impact of PD-L1 Expression in Malignant Salivary Gland Tumors as Assessed by Established Scoring Criteria: Tumor Proportion Score (TPS), Combined Positivity Score (CPS), and Immune Cell (IC) Infiltrate.

Authors:  Hanno M Witte; Niklas Gebauer; Daniela Lappöhn; Vincent G Umathum; Armin Riecke; Annette Arndt; Konrad Steinestel
Journal:  Cancers (Basel)       Date:  2020-04-03       Impact factor: 6.639
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.